Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-26 @ 4:00 AM
Study NCT ID:
NCT00689494
Status:
UNKNOWN
Last Update Posted:
2008-06-03
First Post:
2008-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cervical Device Contraception-2 (Nanopaz)
Sponsor:
Bnai Zion Medical Center
Organization:
Study Overview
Official Title:
Cervical Device Contraception
Status:
UNKNOWN
Status Verified Date:
2008-06
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NANOPAZ
Brief Summary:
Measure blood progesterone by using cervical device contraception.
Detailed Description:
A very small cervical device that releases small amount of progesterone 20 mcgm/day.
The target of the research is to measure blood progesterone by using the cervical device.
This small device delivers progesterone by nanotechnology method.
The target of the research is to measure blood progesterone by using the cervical device.
This small device delivers progesterone by nanotechnology method.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: